MSD in $2B autoimmune buy

By Megan Brodie 3 years ago | In Companies
  • 3 years ago

1 March 2021 MSD is looking to further expand its autoimmune pipeline with a US$1.85…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads